Pfizer Inc.
ANTIBODIES SPECIFIC FOR CD3 AND USES THEREOF
Last updated:
Abstract:
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
Status:
Application
Type:
Utility
Filling date:
21 May 2019
Issue date:
19 Dec 2019